Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: doxorubicin

June 19, 2022 Drug delivery / Pharma applications

Carrier in carrier: Catanionic vesicles based on amphiphilic cyclodextrins complexed with DNA as nanocarriers of doxorubicin

The aim of this study was to evaluate the interaction between catanionic vesicles based on amphiphilic cyclodextrins (ModCBHD) and DNA–Doxorubicin

Continue reading

March 12, 2022 Drug delivery

Cancer-Related Intracellular Signalling Pathways Activated by Doxorubicin/Cyclodextrin-Graphene-Based Nanomaterials

In the last decade, nanotechnological progress has generated new opportunities to improve the safety and efficacy of conventional anticancer therapies.

Continue reading

February 14, 2022 CD derivatives / Drug delivery / Pharma applications

D-maltose clicked to β-cyclodextrin: preparation and its application as a biocompatible drug delivery nanovehicle

D-maltose-clicked derivative of β-cyclodextrin (β-CD-M) was synthesized to compare and investigate its capability as an anticancer drug nanocarrier [1]. The

Continue reading

September 6, 2019 CD derivatives / Drug delivery

Engineered cyclodextrin derivatives for spontaneous coating of highly porous metal-organic framework nanoparticles

Nanosized metal-organic frameworks (nanoMOFs) MIL-100(Fe) are highly porous and biodegradable materials that have emerged as promising drug nanocarriers. A challenging

Continue reading

Recent Posts

  • V International Summer School on Cyclodextrins
  • Recent important review articles from Thorsteinn Loftsson’s group about ophthalmic drug delivery
  • Application of cyclodextrin containing sliding-ring polymers in oil-well cement
  • Oligomer Sensor Nanoarchitectonics for “Turn-On” Fluorescence Detection of Cholesterol at the Nanomolar Level
  • CIDALTEX® ANTIVIRAL MASKS DURING THE COVID-19 PANDEMIC

Tags

antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis Trappsol wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (28)
  • CD as API (178)
  • CD derivatives (231)
  • Cosmetics and toilettry (18)
  • Drug delivery (348)
  • E-ducation (49)
  • Environmental (62)
  • Events (150)
  • Food (100)
  • Gene delivery (8)
  • In Hungarian (4)
  • Life sciences (8)
  • Non-pharma applications (166)
  • Other industrial use (52)
  • Pharma applications (588)
  • Supramolecular systems (19)
  • Uncategorized (34)

Top Posts

  • Recent important review articles from Thorsteinn Loftsson's group about ophthalmic drug delivery
  • V International Summer School on Cyclodextrins
  • Alpha-CD powder and tablets in Japan
  • CIDALTEX® ANTIVIRAL MASKS DURING THE COVID-19 PANDEMIC
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Matthieu SOLLOGOUB at ICS 20
  • GRAS status of CD derivatives
  • Mallinckrodt gave up further development of adrabetadex (VTS-270; HPBCD)
  • Application of cyclodextrin containing sliding-ring polymers in oil-well cement
  • Egg-Free Bakery - Recommendation from Wacker

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 458 other subscribers

 

Loading Comments...